NCT03745248 is a NA clinical trial of Aerobic training in Ataxia, sponsored by Columbia University.

Who is sponsoring NCT03745248?

NCT03745248 is sponsored by Columbia University.

What drugs are being tested in NCT03745248?

Interventions in NCT03745248: Aerobic training, Balance Training.

What condition does NCT03745248 study?

NCT03745248 studies Ataxia, Spino Cerebellar Degeneration, Spinocerebellar Ataxias.

Is NCT03745248 still recruiting?

NCT03745248 is currently completed. Last updated 11 December 2019.

Last reviewed 2019-12-11 · How we verify

NCT03745248

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aerobic Exercise, Balance Training, and Ataxia

Completed NA Last updated 11 December 2019

What this trial tests

NA trial testing Aerobic training in Ataxia in 20 participants. Completed in 14 October 2019.

Timeline

14 November 2018

Primary endpoint
9 June 2019

14 October 2019

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	14 November 2018
Primary completion	9 June 2019
Estimated completion	14 October 2019
Sites	1 location across United States

Drugs / interventions tested

Aerobic training
Balance Training

Conditions studied

Ataxia — all drugs for Ataxia →
Spino Cerebellar Degeneration — all drugs for Spino Cerebellar Degeneration →
Spinocerebellar Ataxias — all drugs for Spinocerebellar Ataxias →

Sponsor

Columbia University

Who can join

18 and older, any sex, with Ataxia or Spino Cerebellar Degeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The first aim is to show aerobic training improves degenerative cerebellar patients functionally The second aim is to compare the effects of balance and aerobic training on degenerative cerebellar disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease.
Barbuto S, Martelli D, Omofuma IB, Lee N, et al · · 2020 · cited 15× · PMID 32037861 · DOI 10.1177/0269215520905073
Phase I Single-Blinded Randomized Controlled Trial Comparing Balance and Aerobic Training in Degenerative Cerebellar Disease.
Barbuto S, Martelli D, Isirame O, Lee N, et al · · 2021 · cited 10× · PMID 32383352 · DOI 10.1002/pmrj.12401

Verify or expand the search:

Other trials of Aerobic training

Trials testing the same drug.

NCT07447037 — Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure · NA · not yet recruiting
NCT07478146 — Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease · NA · recruiting
NCT06795854 — Effect of Aerobic Training Versus Relaxation Techniques on Quality of Life in Patients With Post Covid-19 Irritable Bowe · NA · not yet recruiting
NCT06741384 — Breathing Exercises on Depression in Postmenopausal Women · NA · not yet recruiting
NCT06716008 — Manual Diaphragmatic Release on Ventilatory Functions in Women With Rheumatoid Arthritis · NA · not yet recruiting

Other recruiting trials for Ataxia

Currently open trials in the same condition.

NCT06420271 — Effects of Cerebellar tACS-iTBS in Ataxia · NA · recruiting
NCT06585605 — A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia · recruiting
NCT05443906 — Home Exercise for Individuals with Neurodegenerative Disease · NA · recruiting
NCT06958341 — Neuroimmunology Registry and Biobank · recruiting
NCT03881930 — Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy · NA · recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03745248 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 11 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing